Status:
COMPLETED
Description of the Functional Evolution of Diffuse Infiltrating Pneumonia Associated With Systemic Scleroderma.
Lead Sponsor:
University Hospital, Lille
Conditions:
Systemic Sclerosis
Eligibility:
All Genders
18-75 years
Brief Summary
Diffuse infiltrating pneumonia (DIP) is a severe complication of systemic sclerosis and one of the leading cause of death in this condition. The main objective of this study is to prospectively descri...
Eligibility Criteria
Inclusion
- systemic sclerosis
- Diffuse Infiltrating Pneumonia
Exclusion
- infection
- other lung diseases
- non French native
Key Trial Info
Start Date :
April 10 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 11 2025
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT03271333
Start Date
April 10 2018
End Date
December 11 2025
Last Update
December 23 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Claude Huriez, CHU
Lille, France
2
AH-HP, Hôpital Saint Antoine
Paris, France, 75571